Israeli Startup MNDL Bio Raises $2 Million for AI-Based Gene Engineering

MNDL Bio, an Israeli startup, has secured $2 million in funding to advance its AI-driven gene optimization platform.

The platform is designed to enhance recombinant DNA technology by shifting away from traditional trial-and-error methods to precise, algorithm-based engineering.

This approach aims to speed up research and development, cut costs, and boost success rates in synthetic biology.

MNDL Bio's innovation is geared towards democratizing access to gene engineering, with the potential to transform product development in a range of industries.

Source: AI Brews